Abstract
Acute coronary syndromes (ACS) represent a large segment of patients with coronary artery disease. This article discusses the algorithm of risk stratification in ACS and the evidence for selecting the invasive strategy in the management of ACS. Antiplatelet and antithrombotic therapy used in the management of ACS is also reviewed. Individualization of the dual antiplatelet therapy and of the anticoagulation regimen used during percutaneous coronary intervention, in order to balance the anti-ischemic benefit versus the bleeding risk, allows a safe coronary revascularization in the particular patient presenting with ACS.
| Original language | English |
|---|---|
| Pages (from-to) | 279-285 |
| Number of pages | 7 |
| Journal | Interventional Cardiology |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2012 |
Keywords
- acute coronary syndrome
- antithrombotic therapy
- dual antiplatelet therapy
- percutaneous coronary intervention
Fingerprint
Dive into the research topics of 'Invasive management of the acute coronary syndromes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver